Repligen Corp (NASDAQ:RGEN)

25.47
Delayed Data
As of Mar 02
 -0.24 / -0.93%
Today’s Change
12.04
Today|||52-Week Range
26.89
+28.64%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close25.71
Today’s open25.79
Day’s range25.45 - 26.89
Volume366,406
Average volume (3 months)327,986
Market cap$841.3M
Dividend yield--
Data as of 3:59pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-44.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio70.8
Price/Sales6.34
Price/Book7.90

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.31-3.54%
TXMDTherapeuticsMD Inc+0.04+0.79%
SGNTSagent Pharmaceutica...+0.70+2.58%
EPZMEpizyme Inc+0.41+1.74%
Data as of 4:01pm ET, 03/02/2015

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account